Podcast
Questions and Answers
What is the primary purpose of the notification requirement for pharmacies in the case of a Class I recall of a prescription drug?
What is the primary purpose of the notification requirement for pharmacies in the case of a Class I recall of a prescription drug?
Under which circumstance would a pharmacy be required to notify patients about a recalled prescription drug?
Under which circumstance would a pharmacy be required to notify patients about a recalled prescription drug?
What is the maximum timeframe allowed for a pharmacy to notify patients after receiving notice of a Class I recall?
What is the maximum timeframe allowed for a pharmacy to notify patients after receiving notice of a Class I recall?
How does the notification requirement differ for pharmacies that are part of a chain?
How does the notification requirement differ for pharmacies that are part of a chain?
Signup and view all the answers
What is the definition of "class I recall" as outlined in the text?
What is the definition of "class I recall" as outlined in the text?
Signup and view all the answers
Study Notes
Class I Recall
- A class I recall occurs when the US FDA determines that a product has a reasonable probability of causing serious adverse health consequences or death.
Prescription Drug Recall Notification
- In the event of a class I recall of a prescription drug, pharmacies must make a reasonable attempt to notify patients who: • Have been prescribed the recalled drug • Are currently taking the recalled drug • Received the drug from the pharmacy
- Notification must be made within three days of the pharmacy being notified of the recall by: • The US FDA • A manufacturer • A wholesaler • Other notice of the recall
- Notification can be provided by: • An individual pharmacy • A central office (in the case of a pharmacy chain)
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers the protocol for pharmacies to follow in the event of a Class I recall of a prescription drug, including notification procedures for affected patients.
